Oppenheimer upgraded Agios Pharma (NASDAQ: AGIO) from Perform to Outperform with a price target of $75.00.Analyst Leah Rush Cann comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE